I’m hanging tough with my holdings in 3D Systems (DDD) and the iShares Nasdaq Biotech ETF (IBB). My reasons are pretty straightforward.
I personally believe 3D-printing is going to revolutionize manufacturing on Earth. We’ve only seen the beginning. This specific company is the leader in the field. There’s nothing blue sky about it.
The company turns a profit, and I believe will soon even pay a small dividend. The market is absurdly manic-depressive in its appraisal of this equity. I have no idea what’s going to happen to this stock over the short-term… nor does anybody else. Over the long-term, though, it’s the best bet I know, and that’s why I’m loaded up with it.
IBB, the ETF for the NASDAQ Biotechnology Index, is my second holding. Trying to pick the winners and avoid the losers in biotechnology is practically impossible for someone without inside information. On the other hand, the field as a whole is finally beginning to bear fruit, and the future appears very bright. This is a way for me to diversify. That’s my rationale.
The investments discussed are held in client accounts as of May 31, 2013. These investments may or may not be currently held in client accounts. The reader should not assume that any investments identified were or will be profitable or that any investment recommendations or investment decisions we make in the future will be profitable.
